BMY Bristol Myers Squibb Co

-0.65 (-1.11%)
After Hours
Last Updated: 18:11:15
Delayed by 15 minutes

Register Free for Streaming Quotes & Tools

Register for Free to get streaming quotes, interactive charts, trades, portfolio, live options flow and more.


Draw Mode:

Volume 11,365,947
Bid Price
Ask Price
News -
Day High 58.75


52 Week Range


Day Low 57.61
Company Name Stock Ticker Symbol Market Type
Bristol Myers Squibb Co BMY NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.65 -1.11% 57.89 18:11:15
Open Price Low Price High Price Close Price Prev Close
58.58 57.61 58.75 57.89 58.54
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
90,037 11,365,947 $ 58.12 $ 660,606,809 - 57.61 - 81.435
Last Trade Time Type Quantity Stock Price Currency
18:11:47 56 $ 57.95 USD

Bristol Myers Squibb (BMY) Options Flow Summary

Overall Flow


Net Premium


Calls / Puts


Buys / Sells




Sweeps Ratio


Bristol Myers Squibb Co Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
120.94B 2.09B - 46.16B 6.33B 3.03 19.12
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Bristol Myers Squibb News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No BMY Message Board. Create One! See More Posts on BMY Message Board See More Message Board Posts

Historical BMY Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week58.8059.4657.6158.888,574,785-0.91-1.55%
1 Month62.9863.0357.6159.8011,803,671-5.09-8.08%
3 Months64.1765.37557.6161.2110,890,350-6.28-9.79%
6 Months68.0471.06557.6163.829,295,190-10.15-14.92%
1 Year70.7481.43557.6168.339,054,530-12.85-18.17%
3 Years59.3781.43553.2266.7410,847,505-1.48-2.49%
5 Years61.6681.43541.1960.8412,223,154-3.77-6.11%

Bristol Myers Squibb Description

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.